Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells - Université de Montpellier
Article Dans Une Revue Cells Année : 2020

Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells

Résumé

In the last few decades, the epithelial cell adhesion molecule (EpCAM) has received increased attention as the main membrane marker used in many enrichment technologies to isolate circulating tumor cells (CTCs). Although there has been a great deal of progress in the implementation of EpCAM-based CTC detection technologies in medical settings, several issues continue to limit their clinical utility. The biology of EpCAM and its role are not completely understood but evidence suggests that the expression of this epithelial cell-surface protein is crucial for metastasis-competent CTCs and may not be lost completely during the epithelial-to-mesenchymal transition. In this review, we summarize the most significant advantages and disadvantages of using EpCAM as a marker for CTC enrichment and its potential biological role in the metastatic cascade.
Fichier principal
Vignette du fichier
cells-09-01836.pdf (1.31 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03367929 , version 1 (06-10-2021)

Licence

Identifiants

Citer

Zahra Eslami-S, Luis Enrique Cortés-Hernández, Catherine Alix-Panabières. Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells. Cells, 2020, 9 (8), pp.1836. ⟨10.3390/cells9081836⟩. ⟨hal-03367929⟩
11 Consultations
59 Téléchargements

Altmetric

Partager

More